Translational Transplantation Tolerance Cooperative Study Group

The Translational Transplantation Tolerance Cooperative Study Group program is a forecasted federal funding opportunity administered by the National Institutes of Health within the U.S. Department of Health and Human Services, specifically through the National Institute of Allergy and Infectious Diseases. The program is designed to advance the agency’s mission of improving human health by supporting innovative research in transplantation science. It is structured as a cooperative agreement, indicating substantial involvement from the funding agency in programmatic direction and collaboration with award recipients. The initiative aligns with federal authorities under the Public Health Service Act and applicable federal regulations governing research funding. The primary objective of this program is to accelerate the clinical translation of safe and effective transplantation tolerance strategies. The goal is to enable long-term graft survival without the need for lifelong immunosuppressive therapy, which is currently a major limitation in transplant medicine. By supporting a coordinated, multi-center research effort, the program seeks to develop, optimize, and evaluate approaches that induce and maintain immune tolerance in recipients of allogeneic transplants. These approaches are expected to be tested in translationally relevant models that can bridge the gap between laboratory research and clinical application. Funding will support the establishment and operation of a cooperative study group composed of multiple research centers working collaboratively. Activities may include preclinical and clinical research, development of tolerance-inducing regimens, and evaluation of immune mechanisms underlying transplant acceptance. The cooperative structure implies shared governance, data coordination, and standardized protocols across participating sites. While specific allowable costs are not detailed in the forecast, typical NIH cooperative agreements support personnel, research activities, equipment, and administrative coordination necessary to achieve program goals. There is no cost sharing or matching requirement associated with this opportunity. Eligibility for this program is broad and inclusive, encompassing a wide range of organizational types. Eligible applicants include institutions of higher education, nonprofit organizations with or without 501(c)(3) status, small businesses, for-profit organizations, state and local governments, tribal governments and organizations, independent school districts, public housing authorities, and other entities such as federal agencies, U.S. territories, faith-based organizations, and regional entities. This broad eligibility reflects the collaborative and interdisciplinary nature of transplantation research and the need for diverse institutional participation. The application process is expected to follow standard NIH submission procedures, likely requiring registration in federal systems and submission through designated electronic portals. While specific application components are not yet detailed in the forecast, applicants can anticipate requirements such as research strategy narratives, budgets, biosketches, and institutional documentation. As a cooperative agreement, proposals may also be evaluated on the ability to collaborate effectively within a multi-center framework. Review criteria will likely include scientific merit, feasibility, innovation, and alignment with program objectives. The timeline for this opportunity is currently in the forecast stage. The estimated posting date is January 21, 2027, with an anticipated application due date of May 21, 2027. Awards are expected to be issued by May 1, 2028, with project start dates aligned to the same timeframe. As a forecasted opportunity, these dates are subject to change and applicants are encouraged to monitor official announcements for updates. No recurring cycle is indicated, and this appears to be a single planned funding round based on currently available information. For additional information or inquiries, applicants are directed to contact the Division of Allergy, Immunology, and Transplantation via email. The program provides a centralized contact inbox to facilitate communication regarding eligibility, application requirements, and program scope. Interested applicants should prepare in advance for a complex, multi-institutional research submission and ensure readiness to engage in a cooperative research environment.